Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82401-82450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04930653
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
PHASE2Recruiting
34 participants
Started: Oct 19, 2022 · Completed: Jun 15, 2028
8 conditions2 sponsors3 locations
NCT05368428
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
NARecruiting
27 participants
Started: Oct 19, 2022 · Completed: Mar 31, 2027
22 conditions2 sponsors3 locations
NCT05692739
Clinical Trial to Determine the Effectiveness and Safety of Topical Insulin in Dry Eye
PHASE4Recruiting
120 participants
Started: Oct 19, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05687968
Innovative Approaches in Diabetes Care
NARecruiting
39 participants
Started: Oct 19, 2022 · Completed: Oct 1, 2025
3 conditions1 sponsor1 location
NCT06017011
Clinico-Radiological Characterisation for Remission of Acute Charcot-Neuroarthropathy of Foot.
N/ARecruiting
25 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05445544
A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
N/ARecruiting
10,000 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2027
2 conditions6 sponsors2 locations
NCT05033808
Epirubicin for the Treatment of Sepsis & Septic Shock
PHASE2Recruiting
45 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors5 locations
NCT05391750
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
PHASE1Recruiting
72 participants
Started: Oct 19, 2022 · Completed: Feb 12, 2027
2 conditions2 sponsors1 location
NCT07201038
Ultrafast Whole Genome Sequencing for Childhood Cancer
N/ARecruiting
100 participants
Started: Oct 19, 2022 · Completed: Oct 17, 2028
1 condition3 sponsors1 location
NCT05557760
Effects of Booster Sessions on Depression Vulnerability Following Cognitive Control Training
NARecruiting
138 participants
Started: Oct 18, 2022 · Completed: Sep 30, 2024
1 condition3 sponsors2 locations
NCT06217315
Endometriosis and Health Care System Utilization in British Columbia
N/AActive, not recruiting
1,000,000 participants
Started: Oct 18, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05668884
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
PHASE2Recruiting
93 participants
Started: Oct 18, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04942639
Evaluation of Efficacy and Tolerance of JOE on 4 to 11 Years Old Asthmatic Patients of GINA 2,3,4 and 5 Grades
NAActive, not recruiting
213 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors13 locations
NCT05595447
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
PHASE2/PHASE3Recruiting
20 participants
Started: Oct 18, 2022 · Completed: Oct 18, 2025
3 conditions2 sponsors1 location
NCT05665920
Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy
NARecruiting
36 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04899544
Trial of Center-Based Vs. In-Home Pivotal Response Treatment (PRT) in Autism
NARecruiting
120 participants
Started: Oct 18, 2022 · Completed: Sep 15, 2026
3 conditions2 sponsors1 location
NCT06399432
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
NARecruiting
36 participants
Started: Oct 18, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05443529
Adaptive Sports for Individuals With a Physical Disability : Effect Among Stroke Survivors
N/ARecruiting
50 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05466552
The PROTECT-EU Study
N/ARecruiting
859 participants
Started: Oct 18, 2022 · Completed: Jun 1, 2024
1 condition3 sponsors1 location
NCT05559359
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
PHASE3Recruiting
360 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors86 locations
NCT05593692
Gender Differences and Age Related Differences in Emergency Department Admission
N/ARecruiting
15,000 participants
Started: Oct 18, 2022 · Completed: Oct 28, 2025
3 conditions1 sponsor1 location
NCT05540041
Reducing Anxiety of Children and Their Parents in the Pre-Operative Process With Therapeutic Play
NARecruiting
210 participants
Started: Oct 18, 2022 · Completed: May 30, 2025
4 conditions2 sponsors1 location
NCT05066854
INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDiatric Emergency Department
NARecruiting
232 participants
Started: Oct 18, 2022 · Completed: Nov 18, 2025
1 condition1 sponsor4 locations
NCT05223803
TERPS Trial for De Novo Oligometastic Prostate Cancer
PHASE2Recruiting
122 participants
Started: Oct 18, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor9 locations
NCT05459337
Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT)
NAActive, not recruiting
66 participants
Started: Oct 18, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04432883
Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
NARecruiting
50 participants
Started: Oct 18, 2022 · Completed: Apr 30, 2027
2 conditions4 sponsors1 location
NCT05641428
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
PHASE2Recruiting
300 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2027
2 conditions2 sponsors7 locations
NCT05456698
Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
PHASE2Recruiting
31 participants
Started: Oct 18, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05537298
Muscle Recovery After Critical Illness
N/ARecruiting
209 participants
Started: Oct 18, 2022 · Completed: Aug 1, 2027
4 conditions4 sponsors3 locations
NCT05537116
Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving
NAEnrolling by invitation
240 participants
Started: Oct 18, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05593887
Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures
NARecruiting
51 participants
Started: Oct 18, 2022 · Completed: Oct 26, 2025
1 condition1 sponsor1 location
NCT05718492
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
NARecruiting
100 participants
Started: Oct 18, 2022 · Completed: Oct 18, 2026
1 condition1 sponsor1 location
NCT05440110
Cognitive Effects of Theta-burst Stimulation (TBS) in Suspected Non-Alzheimer Disease Pathophysiology (SNAP)
NAEnrolling by invitation
20 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05508867
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
PHASE2Active, not recruiting
203 participants
Started: Oct 18, 2022 · Completed: Jan 8, 2026
1 condition1 sponsor105 locations
NCT05372354
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
260 participants
Started: Oct 18, 2022 · Completed: Oct 12, 2026
1 condition1 sponsor17 locations
NCT05590949
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
N/ARecruiting
100 participants
Started: Oct 18, 2022 · Completed: Oct 18, 2026
1 condition1 sponsor7 locations
NCT05419531
The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50
N/AActive, not recruiting
100 participants
Started: Oct 18, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05685485
Tied Tube Trial in Glaucoma Surgery
N/ARecruiting
152 participants
Started: Oct 18, 2022 · Completed: Jan 31, 2025
2 conditions3 sponsors1 location
NCT05306327
Neurologic Physiology After Removal of Therapy (NeuPaRT)
N/ARecruiting
108 participants
Started: Oct 18, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor5 locations
NCT05490264
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Oct 18, 2022 · Completed: Jul 30, 2024
2 conditions2 sponsors1 location
NCT05345171
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
PHASE3Active, not recruiting
32 participants
Started: Oct 18, 2022 · Completed: Mar 31, 2031
1 condition1 sponsor16 locations
NCT05245656
A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma
PHASE2Recruiting
90 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06340646
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
NARecruiting
990 participants
Started: Oct 18, 2022 · Completed: Jan 31, 2027
4 conditions3 sponsors1 location
NCT05594576
Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled with GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
NARecruiting
483 participants
Started: Oct 18, 2022 · Completed: Nov 30, 2024
3 conditions2 sponsors2 locations
NCT05570591
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
NARecruiting
60 participants
Started: Oct 18, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors2 locations
NCT04975178
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
PHASE3Recruiting
7,120 participants
Started: Oct 17, 2022 · Completed: Feb 28, 2029
1 condition9 sponsors1 location
NCT05543720
Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study
NARecruiting
350 participants
Started: Oct 17, 2022 · Completed: Sep 30, 2025
5 conditions5 sponsors4 locations
NCT05625607
Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry
N/ARecruiting
100 participants
Started: Oct 17, 2022 · Completed: May 31, 2026
5 conditions7 sponsors7 locations
NCT05482425
Autologous Facial Fat Grafting Study
NAActive, not recruiting
26 participants
Started: Oct 17, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05620134
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
PHASE1/PHASE2Active, not recruiting
263 participants
Started: Oct 17, 2022 · Completed: Feb 20, 2026
22 conditions1 sponsor11 locations